OPRXOptimizeRx Corporation

NAS · US · Healthcare · Health Information Services · optimizerx.com

7.710USD-3.75%Mkt Cap: 145.23M $P/E: 30.843d ago

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Mi…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc Class A

$40.27BUSDP/E 44.0

TEM

Tempus AI Inc. Class A Common Stock

$13.12BUSD

BTSG

BrightSpring Health Services Inc. Common Stock

Hinge Health Inc. Class A Common Stock

$7.14BUSDP/E 10.8

WAY

Waystar Holding Corp. Common Stock

$4.80BUSDP/E 35.7

DOCS

Doximity Inc. Class A Common Stock

$4.51BUSDP/E 30.2

HTFL

Heartflow Inc. Common Stock

$4.33BUSD

PRVA

Privia Health Group, Inc.

Omada Health Inc. Common Stock

GoodRx Holdings, Inc.

Talkspace Inc. Common Stock

SOPHiA GENETICS SA Ordinary Shares

$736.36MUSD

Key Statistics

Company

Market Cap145.23M $

Enterprise Value145.32M $

Revenue (TTM)98.65M $

Gross Profit73.59M $

Net Income (TTM)5.13M $

Revenue/Share5.277 USD

Last Price7.710 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees132

CountryUS

SectorHealthcare

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)30.84

P/E (Forward)7.53

PEG1.61

EV/EBITDA9.35

EV/Revenue1.47

P/S1.52

P/B1.15

EPS (TTM)0.25

EPS (Forward)1.06

52W Range

4.54018% of range22.25

52W High22.25 USD

52W Low4.540 USD

Profitability

Gross Margin67.25%

Oper. Margin-0.43%

EBITDA Margin15.76%

Profit Margin4.69%

ROE4.00%

ROA2.90%

Growth

Revenue Growth-29.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF18.71M $

CapEx (TTM)—

FCF Margin15.98%

FCF Yield10.85%

Net Debt-4.62M $

Net Debt/EBITDA-0.30

Balance Sheet

Debt/Equity0.20

Current Ratio5.58

Quick Ratio5.27

Book Value/Sh6.907 USD

Cash/Share1.279 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateMay 14, 2018

Splits

Last Split1:3

Split DateMay 14, 2018

Analyst Consensus

Rating1.2 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)12.40 USD

Upside (mean)+60.8%

Target Range10.00 USD – 18.00 USD

$10.00+60.8% to mean$18.00

# Analysts5

Ownership

Shares Out.18.84M

Float14.50M

Insiders12.83%

Institutions69.64%

Short Interest

Short Ratio4.7d

Short % Float7.59%

Short % Out.7.24%

Shares Short1.36M

Short (prev mo.)1.13M

Technical

SMA 506.337 (+21.7%)

SMA 2008.837 (-12.8%)

Beta1.05

S&P 52W Chg18.16%

Avg Vol (30d)248.72K

Avg Vol (10d)323.61K

Technical Indicators

RSI (14)59.3

MACD0.5306

MACD Signal0.4306

MACD Hist.+0.1000

BB Upper8.744 USD

BB Middle7.027 USD

BB Lower5.309 USD

BB Width48.89%

ATR (14)0.5201 USD

Vol Ratio (20d)0.52x